Fundraising Fox
Haptena Therapeutics
1 employees on LinkedIn · 1 known investors
Find your way into Haptena Therapeutics
Sign up to see every warm intro you have to Haptena Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Haptena Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Haptena Therapeutics is a biotech company developing next-generation immunotherapies for oncogene-driven, genetically defined cancers, starting with KRAS-driven tumors. It combines targeted therapy precision with immune-based approaches to create more durable treatment options for patients with difficult-to-treat cancers.
Founders & leadership
Investors · 1
How we know: Claris Ventures's portfolio page · funding news · startupbusiness.it · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountseed funding roundDec 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Haptena Therapeutics do?
- Haptena Therapeutics is a biotech company developing next-generation immunotherapies for oncogene-driven, genetically defined cancers, starting with KRAS-driven tumors. It combines targeted therapy precision with immune-based approaches to create more durable treatment options for patients with difficult-to-treat cancers.
- Who founded Haptena Therapeutics?
- Haptena Therapeutics was founded by Chiara Ambrogio, Roberto Chiarle.
- Who are Haptena Therapeutics's investors?
- Haptena Therapeutics's investors include Claris Ventures.